Molecular characteristics of testicular germ cell tumors: pathogenesis and mechanisms of therapy resistance

Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study

(2019) Klaus-Peter Dieckmann et al.   JOURNAL OF CLINICAL ONCOLOGY

Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy Spectrum

(2019) Lucia Nappi et al.   JOURNAL OF CLINICAL ONCOLOGY

Large-scale Sequencing of Testicular Germ Cell Tumour (TGCT) Cases Excludes Major TGCT Predisposition Gene

(2018) Kevin Litchfield et al.   EUROPEAN UROLOGY

Integrated Molecular Characterization of Testicular Germ Cell Tumors

(2018) Hui Shen et al.   Cell Reports

Searching for common ground in a global disease

(2018) Richard S. Finn   HEPATOBILIARY SURGERY AND NUTRITION

Moving from late to early stage disease: lessons learned from erlotinib in pancreatic cancer

(2018) Andrew H. Ko   HEPATOBILIARY SURGERY AND NUTRITION

Increased mutant KRAS gene dosage drives pancreatic cancer progression: evidence for wild-type KRAS as a tumor suppressor?

(2018) Oliver A. Kent   HEPATOBILIARY SURGERY AND NUTRITION

Molecular characterization of testicular germ cell tumors: chasing the underlying pathways

(2018) Michal Chovanec et al.   Future Oncology

Testicular cancer

(2018) Liang Cheng et al.   Nature Reviews Disease Primers

Emerging Prognostic Biomarkers in Testicular Germ Cell Tumors: Looking Beyond Established Practice

(2018) Michal Chovanec et al.   Frontiers in Oncology

The new era of precision medicine in hepatocellular carcinoma: the urgent need for promising biomarkers

(2018) Haruhiko Takeda et al.   HEPATOBILIARY SURGERY AND NUTRITION

Perspectives on testicular germ cell neoplasms

(2017) Liang Cheng et al.   HUMAN PATHOLOGY

Imprints and DPPA3 are bypassed during pluripotency- and differentiation-coupled methylation reprogramming in testicular germ cell tumors

(2016) J. Keith Killian et al.   GENOME RESEARCH

Genomic evolution and chemoresistance in germ-cell tumours

(2016) Amaro Taylor-Weiner et al.   NATURE

The genomic landscape of testicular germ cell tumours: from susceptibility to treatment

(2016) Kevin Litchfield et al.   Nature Reviews Urology

Presence of Somatic Mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in Cisplatin-Resistant Germ Cell Tumors

(2014) D. R. Feldman et al.   CLINICAL CANCER RESEARCH

Cisplatin Induces Resistance by Triggering Differentiation of Testicular Embryonal Carcinoma Cells

(2014) Paolo B. Abada et al.   PLoS One

Molecular biology of testicular germ cell tumors: Unique features awaiting clinical application

(2013) Ludmila Boublikova et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Premalignancy of the testis and paratestis

(2013) Robert E. Emerson et al.   PATHOLOGY

KIT gene mutation and amplification in dysgerminoma of the ovary

(2010) Liang Cheng et al.   CANCER

Microsatellite Instability, Mismatch Repair Deficiency, andBRAFMutation in Treatment-Resistant Germ Cell Tumors

(2009) Friedemann Honecker et al.   JOURNAL OF CLINICAL ONCOLOGY

Seladin-1 and testicular germ cell tumours: new insights into cisplatin responsiveness

(2009) Francesca Nuti et al.   JOURNAL OF PATHOLOGY